🌟 Exciting News from Syreon Middle East! 🌟 We are pleased to announce that our 12 research abstracts submitted to ISPOR—The Professional Society for Health Economics and Outcomes Research Europe 2024 have been accepted for presentation at the conference this November in Barcelona! Our research covers a broad spectrum, including policy research, cost-effectiveness analysis, innovative methodologies, and burden of disease studies. This achievement is a testament to the relentless dedication, expertise, and collaboration of our incredible team members—both internal and external. We are immensely grateful for the hard work and commitment that went into these projects over the past year. ISPOR is the leading conference in our field of health economics, and we are honoured to contribute our insights and research to the global community. We look forward to sharing our findings and engaging in discussions that drive innovation and better health outcomes. Thank you to everyone who played a role in making this happen. Let's continue to push the boundaries of what's possible in health economics! 🚀 #ISPOREurope2024 #HealthEconomics #Syreon #Teamwork #Innovation #ResearchExcellence
Syreon Middle East
خدمات الأبحاث
Experts in health economics, market access and corporate training for the pharmaceutical & health services sector
نبذة عنا
Established in 2017, Syreon Middle East, located in Egypt, provides expert services in the fields of health economics, market access, strategic pricing and corporate training for the pharmaceutical and health services sector to the Middle East region. Syreon Middle East was established in partnership with local experience to offer the best of both worlds, bringing the highest quality scientific research combined with local expert knowledge. SME team has a long-standing experience in the pharmaceutical market in the Middle East.
- المجال المهني
- خدمات الأبحاث
- حجم الشركة
- ٢ - ١٠ موظفين
- المقر الرئيسي
- Alexandria
- النوع
- شركة يملكها عدد قليل من الأشخاص
- تم التأسيس
- 2017
- التخصصات
- Health Economics، Market Access، Strategic Pricing، Corporate Training، Pharmaceuticals، و Health Services Sector
المواقع الجغرافية
-
رئيسي
142 El-Shaheed Galal El-Desouky Street
Alexandria، EG
موظفين في Syreon Middle East
التحديثات
-
أعاد Syreon Middle East نشر هذا
We are pleased to announce the release of our latest scientific manuscript titled "Designing a Roadmap for Health Technology Assessment Implementation in Algeria." This collaborative effort outlines the current status and future directions for HTA implementation in Algeria, addressing critical gaps and proposing strategic actions for a sustainable and effective healthcare system. Key highlights of the study: -Analysis of the current HTA environment in Algeria, identifying strengths and areas for improvement. -Recommendations for capacity building, including expanding the postgraduate HTA training programs. -Proposals for sustainable HTA funding mechanisms, involving both public and private sectors. -Emphasis on the need for local HTA evidence generation and the integration of multi-criteria decision analysis (MCDA) in policy decisions. -Strategies for enhancing the quality and transparency of HTA processes. Read full article: https://lnkd.in/dPhPA_jy This publication is a significant step towards advancing health economics and evidence-based decision-making in the MENA region, contributing to better healthcare outcomes and resource allocation. Meriem HEDIBEL Fatma Zohra Ghanassi Kareem El-Fass BSc, PharmD, MSc Ahmad Fasseeh Sherif Abaza ,MBA Zoltán Kaló #HealthEconomics #HTA #Algeria #Healthcare #SyreonMiddleEast #EvidenceBasedMedicine #HealthcarePolicy #MENA
-
We are pleased to announce the release of our latest scientific manuscript titled "Designing a Roadmap for Health Technology Assessment Implementation in Algeria." This collaborative effort outlines the current status and future directions for HTA implementation in Algeria, addressing critical gaps and proposing strategic actions for a sustainable and effective healthcare system. Key highlights of the study: -Analysis of the current HTA environment in Algeria, identifying strengths and areas for improvement. -Recommendations for capacity building, including expanding the postgraduate HTA training programs. -Proposals for sustainable HTA funding mechanisms, involving both public and private sectors. -Emphasis on the need for local HTA evidence generation and the integration of multi-criteria decision analysis (MCDA) in policy decisions. -Strategies for enhancing the quality and transparency of HTA processes. Read full article: https://lnkd.in/dPhPA_jy This publication is a significant step towards advancing health economics and evidence-based decision-making in the MENA region, contributing to better healthcare outcomes and resource allocation. Meriem HEDIBEL Fatma Zohra Ghanassi Kareem El-Fass BSc, PharmD, MSc Ahmad Fasseeh Sherif Abaza ,MBA Zoltán Kaló #HealthEconomics #HTA #Algeria #Healthcare #SyreonMiddleEast #EvidenceBasedMedicine #HealthcarePolicy #MENA
Designing a Roadmap for Health Technology Assessment Implementation in Algeria
cureus.com
-
أعاد Syreon Middle East نشر هذا
Syreon Middle East is excited to announce our collaborative project with leading experts in Oman to develop a national Health Technology Assessment (HTA) implementation plan. This initiative underscores the dedication of various stakeholders from both governmental and non-governmental sectors in Oman, showcasing their commitment to evidence-based decision-making and HTA implementation in healthcare. This collaboration highlights the strategic steps Oman is taking to integrate HTA into their healthcare system, which will enhance efficiency and sustainability. The involvement of multiple stakeholders not only emphasizes the political commitment but also the collective effort towards improving healthcare outcomes through informed decisions. For an in-depth look at our collaborative efforts and the detailed roadmap developed, read the full manuscript: https://lnkd.in/dRi8xdsE We are grateful to all co-authors and contributors who have brought this significant project to completion. Their expertise and commitment have been crucial in shaping a comprehensive HTA framework tailored for Oman. Ibrahim Alrashdi, sara albalushi, Alia Al Shuaili, said wani, Nadiya AlBulushi Gla AlBulushi, Asiya Ibrahim Al Kindi, Qasem Al Salmi, Hilal Alsabti, Nada Korra, Sherif Abaza ,MBA, Ahmad Fasseeh, Zoltán Kaló #HealthEconomics #HTA #OmanHealth #PublicHealth #HealthcarePolicy #EvidenceBasedDecisionMaking
A roadmap towards implementing health technology assessment in Oman
emerald.com
-
Syreon Middle East is excited to announce our collaborative project with leading experts in Oman to develop a national Health Technology Assessment (HTA) implementation plan. This initiative underscores the dedication of various stakeholders from both governmental and non-governmental sectors in Oman, showcasing their commitment to evidence-based decision-making and HTA implementation in healthcare. This collaboration highlights the strategic steps Oman is taking to integrate HTA into their healthcare system, which will enhance efficiency and sustainability. The involvement of multiple stakeholders not only emphasizes the political commitment but also the collective effort towards improving healthcare outcomes through informed decisions. For an in-depth look at our collaborative efforts and the detailed roadmap developed, read the full manuscript: https://lnkd.in/dRi8xdsE We are grateful to all co-authors and contributors who have brought this significant project to completion. Their expertise and commitment have been crucial in shaping a comprehensive HTA framework tailored for Oman. Ibrahim Alrashdi, sara albalushi, Alia Al Shuaili, said wani, Nadiya AlBulushi Gla AlBulushi, Asiya Ibrahim Al Kindi, Qasem Al Salmi, Hilal Alsabti, Nada Korra, Sherif Abaza ,MBA, Ahmad Fasseeh, Zoltán Kaló #HealthEconomics #HTA #OmanHealth #PublicHealth #HealthcarePolicy #EvidenceBasedDecisionMaking
A roadmap towards implementing health technology assessment in Oman
emerald.com
-
أعاد Syreon Middle East نشر هذا
In a significant stride toward enhancing health economics in the UAE, Syreon Middle East is proud to announce our latest collaboration with esteemed experts across the UAE. Together, we have crafted pivotal recommendations for a national Health Technology Assessment (HTA) implementation plan. Our collaborative effort underscores a robust commitment from various governmental and non-governmental entities in the UAE. This initiative not only reflects the dedication to evidence-based decision-making but also marks a significant step in the implementation of HTA in the region. The involvement of diverse stakeholders highlights the political resolve to adopt and integrate HTA practices that will shape the future of healthcare in the UAE. To read the full article: https://lnkd.in/d_HUB7aB We extend our gratitude to all co-authors and contributors from various sectors who have played a crucial role in this project Khalid Alnaqbi, MD MSc, CCD, FRCPC, FACP, FACR, Amin Elshamy, Nicole Gebran Connell, PharmD, BCPS, SQIL(HMS), Sahar Fahmy Dr. Sara Al Dallal Nada Korra Ahmad Fasseeh Zoltán Kaló. Their expertise and insights have been invaluable in developing a tailored, effective HTA framework. #HealthEconomics #HTA #UAEHealth #PublicHealth #HealthcarePolicy #EvidenceBasedDecisionMaking
-
In a significant stride toward enhancing health economics in the UAE, Syreon Middle East is proud to announce our latest collaboration with esteemed experts across the UAE. Together, we have crafted pivotal recommendations for a national Health Technology Assessment (HTA) implementation plan. Our collaborative effort underscores a robust commitment from various governmental and non-governmental entities in the UAE. This initiative not only reflects the dedication to evidence-based decision-making but also marks a significant step in the implementation of HTA in the region. The involvement of diverse stakeholders highlights the political resolve to adopt and integrate HTA practices that will shape the future of healthcare in the UAE. To read the full article: https://lnkd.in/d_HUB7aB We extend our gratitude to all co-authors and contributors from various sectors who have played a crucial role in this project Khalid Alnaqbi, MD MSc, CCD, FRCPC, FACP, FACR, Amin Elshamy, Nicole Gebran Connell, PharmD, BCPS, SQIL(HMS), Sahar Fahmy Dr. Sara Al Dallal Nada Korra Ahmad Fasseeh Zoltán Kaló. Their expertise and insights have been invaluable in developing a tailored, effective HTA framework. #HealthEconomics #HTA #UAEHealth #PublicHealth #HealthcarePolicy #EvidenceBasedDecisionMaking
-
أعاد Syreon Middle East نشر هذا
Syreon Middle East is pleased to share that our team recently conducted a comprehensive training session on model validation in Amman, Jordan. This workshop focused on essential aspects of model validation, including the validation of model design and assumptions, computational accuracy, and external validation against real-world data. This training aimed to enhance participants' skills in validating health economic models, ultimately contributing to more effective healthcare decision-making. #HealthEconomics #Syreon
-
Syreon Middle East is pleased to share that our team recently conducted a comprehensive training session on model validation in Amman, Jordan. This workshop focused on essential aspects of model validation, including the validation of model design and assumptions, computational accuracy, and external validation against real-world data. This training aimed to enhance participants' skills in validating health economic models, ultimately contributing to more effective healthcare decision-making. #HealthEconomics #Syreon
-
أعاد Syreon Middle East نشر هذا
Syreon Middle East is excited to share the publication of our recent scientific manuscript, Framework for Developing Cost-Effectiveness Analysis Threshold: The Case of Egypt. This collaborative effort introduces a Cost-Effectiveness Threshold (CET) framework meticulously crafted for the Egyptian healthcare landscape, emphasizing the relationship between health gains and economic benchmarks. Central to our findings, the national expert panel advocates for the establishment of variable CETs in Egypt linked to the GDP per capita. This approach permits each new healthcare intervention to be evaluated against a base threshold, augmented by specific multipliers reflecting relative health gains and the rarity of conditions. Key Insights: · A foundational threshold set at 1X the GDP per capita serves as the cornerstone, with potential amplification up to 3X, guided by the Incremental Relative Quality-Adjusted Life Years (QALY) Gain and rarity. · For orphan drugs, a special CET multiplier ranging from 1.5 to 3.0 was recommended, further refining the assessment based on disease rarity. · The framework proposes a differential approach to private reimbursement, recommending a multiplier of two compared to public sectors to reflect distinct economic realities. A thoughtful one-year pilot phase for the framework's implementation was strongly recommended by participants, ensuring a meticulous evaluation of its applicability and impact. We would like to thank our co-authors and research contributors for their commitment to enhancing health economics practices within Egypt and the MENA region Ahmad Fasseeh Nada Korra Baher ElEzbawy Amal Sedrak mary kirollos Randa Eldessouki Mariam El-Debeiky,MBA mohsen george Ahmed Seyam Asmaa Abourawash Ahmed Yehia Khalifa Mayada Shaheen Sherif Abaza ,MBA Zoltán Kaló . This publication reaffirms our dedication to supporting sustainable, evidence-based healthcare policies. We invite our community of healthcare experts, policymakers, and scholars to read the publication here: https://lnkd.in/gWBp7set #HealthEconomics #PublicHealth #Egypt #CostEffectiveness #HealthcarePolicy #InnovationInHealthcare